Original research
by
Amram, Ofer et al
Release Date
2022
Geography
USA
Language of Resource
English
Full Text Available
Yes
Open Access / OK to Reproduce
No
Peer Reviewed
Yes
Objective
We assessed the adoption of increased take-home medication during COVID-19 and whether increased take-home doses is associated with clients' characteristics.
Findings/Key points
Take-home medication dosing expansion as a result of COVID-19 exemption was quickly adopted and take-home dosing was broadly expanded among clients.
Design/methods
We completed a pre-post study of adults receiving methadone for OUD from an OTP in Spokane, Washington
Keywords
Policy/Regulatory
About PWUD
Illegal drugs
Substitution/OAT
Carries/take-home doses
